Média

AMAG PHARMACEUTICALS ET NORGINE B.V. CONCLUENT UN ACCORD DE LICENCE EXCLUSIVE POUR COMMERCIALISER CIRAPARANTAG EN EUROPE, AUSTRALIE ET NOUVELLE- ZÉLANDE
08 Septembre 2020

NORGINE A FAIT L’ACQUISITION DU LABORATOIRE AZANTA, RENFORÇANT SA POSITION DE LABORATOIRE PHARMACEUTIQUE LEADER EUROPEEN
19 Mai 2020

Voir plus

Media releases archive

Media contacts: contact@norgine.com, T: +44(0) 1895 826 654 and T: +44(0) 1895 826 227

These media releases are intended for business/trade media and for analysts/investors

 

Sign up for Norgine alerts

    Your e-mail address will only be used to provide you with media alerts from Norgine.com. Your personal information will not be provided to any third party without your permission.

    [recaptcha size:compact]